- Home
- NVO vs V Comparison
NVO vs V Comparison
Compare NVO & V Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NVO | V |
|---|---|---|
| Founded | 1923 | 1958 |
| Country | Denmark | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 212.7B | 676.2B |
| IPO Year | N/A | 2008 |
Fundamental Metrics
Financial Performance| Metric | NVO | V |
|---|---|---|
| Price | $52.24 | $345.98 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 11 | 25 |
| Target Price | $54.25 | ★ $398.88 |
| AVG Volume (30 Days) | ★ 15.5M | 5.9M |
| Earning Date | 02-04-2026 | 01-29-2026 |
| Dividend Yield | ★ 2.35% | 0.77% |
| EPS Growth | ★ 10.06 | 4.85 |
| EPS | 3.67 | ★ 10.20 |
| Revenue | ★ $49,580,393,058.00 | $40,000,000,000.00 |
| Revenue This Year | $7.25 | $13.35 |
| Revenue Next Year | $0.24 | $10.15 |
| P/E Ratio | ★ $14.15 | $33.96 |
| Revenue Growth | ★ 16.64 | 11.34 |
| 52 Week Low | $43.08 | $299.00 |
| 52 Week High | $93.80 | $375.51 |
Technical Indicators
Market Signals| Indicator | NVO | V |
|---|---|---|
| Relative Strength Index (RSI) | 59.90 | 52.75 |
| Support Level | $50.55 | $343.68 |
| Resistance Level | $53.63 | $355.20 |
| Average True Range (ATR) | 1.05 | 3.80 |
| MACD | 0.37 | 0.23 |
| Stochastic Oscillator | 77.27 | 18.86 |
Price Performance
Historical ComparisonAbout NVO Novo Nordisk A/S
With roughly one-third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (contributing less than 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.
About V Visa Inc.
Visa is the largest payment processor in the world. In fiscal 2025, it processed almost $17 trillion in total volume. Visa operates in over 200 countries and processes transactions in over 160 currencies. Its systems are capable of processing over 65,000 transactions per second.